We’re driven to make a difference on behalf of patients. And that means seeking out innovation wherever it may live—inside and outside our walls.
We partner across the entire healthcare ecosystem—pharmaceutical companies, academic institutions, physician groups and more. Because we believe that collaboration is the best way to yield new ideas and products.
We pursue diverse development streams that both leverage our heritage in diagnostic imaging and expand our reach into novel therapeutics. Although our specialty areas include oncology and cardiology, we remain open to and interested in all disciplines where our expertise could make a difference in the lives of patients.
Some of our partnership categories include theranostics, microbubble technology, imaging biomarkers and digital services that leverage artificial intelligence (AI) to enhance diagnosis and treatment. We believe that focusing on these emerging technologies will help us deliver on the promise of precision medicine.
We embrace a variety of flexible partnership structures. These include in- and out-licensing arrangements, as well as product and company acquisitions.
Our partnerships are built on inclusiveness, openness and transparency. We believe in fair and equitable relationships. And, above all, we embrace flexibility to achieve our shared goals.